Home
Medicines
Companies
COVID-19
Active Ingredients
Advanced Search
Adverse Event Reporting
Login
Search Medicine Database
Home
Medicines
Companies
COVID-19
More
expand_more
Login
menu
Home
Active Ingredients
Ravulizumab
Ravulizumab
Medicine
Status
PIL
SPC
XPIL
EDM - Patient
EDM - HCP
Legal Category
Active Ingredient(s)
Company
Ultomiris 1100mg/11ml
Updated
PIL
08/10/21
SPC
08/10/21
Yes
EDM
26/01/22
EDM
26/01/22
C
Ravulizumab
Alexion Pharma UK Ltd
Ultomiris 300mg/30ml
Updated
PIL
08/10/21
SPC
08/10/21
Yes
EDM
26/01/22
EDM
26/01/22
C
Ravulizumab
Alexion Pharma UK Ltd
Ultomiris 300mg/3ml
Updated
PIL
08/10/21
SPC
08/10/21
Yes
EDM
26/01/22
EDM
26/01/22
C
Ravulizumab
Alexion Pharma UK Ltd
Documents associated with this medicine were updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to restricted prescription (C)
